TickerFacts.

Company research / ENTX

Entera Bio Ltd. (ENTX)

Build a valuation ↗↓ Download CSV

CIK 0001638097 · Nasdaq · Biological Products, (No Diagnostic Substances)

  • Sector Manufacturing
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Entera Bio Ltd. reported revenue of $42.0K. Revenue fell 76.8% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $0.

Key ratios (year ended 2025-12-31)

0.0%
Gross margin
n/m
Operating margin
n/m
Net margin
-87.3%
Return on year-end equity
-76.8%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form DEF 14A (proxy statement) · 2026-10-14

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-31
Revenue$0$42.0K$181.0K$0$134.0K$571.0K$365.0K
Cost of Revenue$0$42.0K$172.0K$0$101.0K$373.0K$300.0K
Gross Profit$0$0$9.0K$0$33.0K$198.0K$65.0K
R&D Expense$8.81M$6.00M$4.50M$4.51M$5.85M$6.77M$6.38M
Operating Income-$14.40M-$11.53M-$9.59M-$8.89M-$13.02M-$12.22M-$11.17M
Net Income-$17.03M-$11.44M-$9.54M-$8.89M-$13.07M-$12.19M-$11.22M
EPS (Diluted)n/a$0.25$0.25$0.31$0.45$0.47n/a
Total Assets$19.48M$15.99M$9.39M$11.77M$13.13M$25.99M$9.72M
Total Liabilities$12.21M$2.89M$1.31M$1.38M$1.37M$3.42M$2.21M
Shareholders' Equity$7.27M$13.10M$8.08M$10.39M$11.75M$22.57M$7.51M
Cash & Equivalents$11.31M$7.11M$8.66M$11.02M$12.31M$24.89M$8.59M
Operating Cash Flow-$10.89M-$7.37M-$6.82M-$7.31M-$12.50M-$9.06M-$10.56M
Capital Expenditures$73.0K$107.0K$3.0K$17.0K$47.0K$17.0K$53.0K
Free Cash Flow-$10.96M-$7.48M-$6.82M-$7.33M-$12.55M-$9.08M-$10.61M
Shares Outstanding49.29M46.18M38.84M35.48M28.81M28.80M21.06M
Weighted Average Diluted Sharesn/a46.19M37.65M29.01M28.81M26.13Mn/a
EPS (Basic)n/a$0.25$0.25$0.31$0.45$0.47n/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView